<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03485898</url>
  </required_header>
  <id_info>
    <org_study_id>2017-CHITS-05</org_study_id>
    <secondary_id>2017-A03332-51</secondary_id>
    <nct_id>NCT03485898</nct_id>
  </id_info>
  <brief_title>Study of Patients Hospitalized in Specialized Cognitive-behavioral Unit (UCC)</brief_title>
  <acronym>UCC</acronym>
  <official_title>Patient Outcomes After an Hospitalization in the Specialized Cognitive-behavioral Unit (UCC) of Toulon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to assess the mortality of patient discharged from the
      specialized cognitive-behavioral unit (UCC) of Toulon.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of specialized cognitive-behavioral unit is to take care of patients demented,
      valid and with disruptive behavior disorders. The hypothesis is that analyzing the healthcare
      of these discharged patients might provide a view of the benefices of these units.

      The study will be explained to the eligible subjects if they are able to understand it, or to
      their trusted person, primary caregiver or legal representative.

      Medical information will be collected during and after the hospitalization in the specialized
      cognitive-behavioral unit. The investigator will call the medical staff and the primary
      caregiver at 3, 6, and 12 months after the patient's discharge, in order to collect study
      data.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2018</start_date>
  <completion_date type="Anticipated">July 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality rate at 12 month after patient's discharge from UCC</measure>
    <time_frame>12 months</time_frame>
    <description>Number of dead patient at 12 month on the total number of patient included</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality rate at 3 and 6 month after patient's discharge from UCC</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>Number of dead patient at 3 and 6 month on the total number of patient included</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess the primary mortality risk factors regarding all the collected data.</measure>
    <time_frame>12 months</time_frame>
    <description>correlation analysis of collected data and survival data will lead to prediction of survival model with the most relevant survival variable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Create a predictive score for 6 and 12 month mortality</measure>
    <time_frame>6 and 12 months</time_frame>
    <description>all the survival variable will have a score according to the survival prediction model - this endpoint is adressed in order to create a predictive scale/score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rate during the hospitalization in the UCC</measure>
    <time_frame>12 months</time_frame>
    <description>Number of all dead patient on the total number of patient included</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of hospitalisation rate</measure>
    <time_frame>12 months</time_frame>
    <description>Descriptive analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of the number of treatment taken during the study</measure>
    <time_frame>12 months</time_frame>
    <description>Descriptive analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of the different classes of treatment taken during the study</measure>
    <time_frame>12 months</time_frame>
    <description>Descriptive analysis of the rate of different classes of treatment taken by patient during the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of the treatment's mode of delivery</measure>
    <time_frame>12 months</time_frame>
    <description>Descriptive analysis</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Behavior Disorders</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The population correspond to all inpatient from the UCC of Toulon
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inpatient at the UCC of Toulon

        Exclusion Criteria:

          -  Patient already included in the study ( a patient cannot be included twice during the
             study)

          -  Non-affiliated to a social security regimen

          -  Objection of the patient, the trusted person, the legal representative, the relative
             or the member of the family (depending on the overall condition of the patient)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romain Van overloop, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Intercommunal Toulon La Seyne sur Mer</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anaïs Maugard</last_name>
    <phone>04.94.14.55.29</phone>
    <phone_ext>+33</phone_ext>
    <email>anais.maugardlandre@ch-toulon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mylène Vernisse</last_name>
    <phone>04.94.14.55.29</phone>
    <phone_ext>+33</phone_ext>
    <email>mylene.vernisse@ch-toulon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal de Toulon La-Seyne-sur-Mer</name>
      <address>
        <city>Toulon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain Van Overloop, Doctor</last_name>
      <phone>0494088676</phone>
      <email>romain.van-overloop@ch-toulon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Walsh JS, Welch HG, Larson EB. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med. 1990 Sep 15;113(6):429-34.</citation>
    <PMID>2386336</PMID>
  </reference>
  <reference>
    <citation>Mölsä PK, Marttila RJ, Rinne UK. Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand. 1986 Aug;74(2):103-7.</citation>
    <PMID>3776457</PMID>
  </reference>
  <reference>
    <citation>Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002 Oct;59(10):1589-93.</citation>
    <PMID>12374497</PMID>
  </reference>
  <reference>
    <citation>Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W. Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci. 2005 Mar 15;229-230:43-9. Epub 2004 Dec 23.</citation>
    <PMID>15760618</PMID>
  </reference>
  <reference>
    <citation>Lee M, Chodosh J. Dementia and life expectancy: what do we know? J Am Med Dir Assoc. 2009 Sep;10(7):466-71. doi: 10.1016/j.jamda.2009.03.014. Epub 2009 Jun 27. Review.</citation>
    <PMID>19716062</PMID>
  </reference>
  <reference>
    <citation>Mitchell SL, Kiely DK, Hamel MB, Park PS, Morris JN, Fries BE. Estimating prognosis for nursing home residents with advanced dementia. JAMA. 2004 Jun 9;291(22):2734-40.</citation>
    <PMID>15187055</PMID>
  </reference>
  <reference>
    <citation>Mitchell SL, Miller SC, Teno JM, Davis RB, Shaffer ML. The advanced dementia prognostic tool: a risk score to estimate survival in nursing home residents with advanced dementia. J Pain Symptom Manage. 2010 Nov;40(5):639-51. doi: 10.1016/j.jpainsymman.2010.02.014.</citation>
    <PMID>20621437</PMID>
  </reference>
  <reference>
    <citation>Mitchell SL, Miller SC, Teno JM, Kiely DK, Davis RB, Shaffer ML. Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. JAMA. 2010 Nov 3;304(17):1929-35. doi: 10.1001/jama.2010.1572.</citation>
    <PMID>21045099</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2018</study_first_submitted>
  <study_first_submitted_qc>March 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2018</study_first_posted>
  <last_update_submitted>April 13, 2018</last_update_submitted>
  <last_update_submitted_qc>April 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>UCC</keyword>
  <keyword>mortality</keyword>
  <keyword>alzheimer's disease</keyword>
  <keyword>longitudinal study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to share IPD</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

